A comprehensive view of Men's Health Issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca, Merck's Lynparza wins EU nod to treat metastatic castration-resistant prostate cancer; 473,000 cases of prostate cancer diagnosed annually in Europe, with 10% to 20% of patients developing CRPC within five years

AstraZeneca and MSD’s Lynparza tablets combined with abiraterone and prednisone or prednisolone now approved in the EU for treatment of metastatic castration-resistant prostate cancer

AstraZeneca reports FDA has extended PDUFA date by three months; extension to provide time for full review of sNDA for Lynparza olaparib combination with abiraterone, prednisone or prednisolone to treat metastatic castration-resistant prostate cancer

Novartis wins EU approval for Pluvicto lutetium Lu 177 vipivotide tetraxetan radiopharmaceutical drug to treat prostate cancer; drug contains radioactive agent that destroys cancer cells, antibody that binds to prostate-specific membrane antigen

Gillette announces support for Movember campaign, consolidating the mustache as a symbol of men's health in Brazil to boost awareness of diseases such as prostate cancer; campaign features Liverpool goalkeeper Alisson Becker growing a mustache in support

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count